Revolutionary weight-loss jab Tirzepatide – which is sold under the name Zepbound – could save patients from life-threatening liver failure, study finds

More than half of patients with fatty liver disease, often triggered by obesity, saw an improvement in their symptoms after being given tirzepatide. More than half of patients with fatty liver disease, often triggered by obesity, saw an improvement in their symptoms after being given tirzepatide.